Over the past 20 years, Yale inventions have led to the creation of nearly 60 companies in the New Haven region that have attracted more than $1 billion of professional venture capital investment and have created over 1,400 jobs in the region. Over half of these have been based on science from Yale Cancer Center members, including:
Achillion logo

Achillion Pharmaceuticals

Yung-Chi Cheng, PhD, Developmental Therapeutics 

alexion logo

Alexion Pharmaceuticals 

Joseph Madri, MD/PhD, Pathology

artizan

Artizan Biosciences

Richard Flavell, PhD, FRS, Cancer Immunology

arvinas logo

Arvinas

Craig Crews, PhD, Developmental Therapeutics

cargient logo
Carigent Therapeutics

W. Mark Saltzman, PhD, Developmental Therapeutics
carogen logo

CaroGen Corporation

John Rose, PhD, VOIC

cavtherx logo

CavtheRx

William Sessa, PhD, Developmental Therapeutics

cybrexa logo

Cybrexa Therapeutics

Ranjit Bindra, MD, PhD, Radiobiology & Radiotherapy and Peter Glazer, MD, PhD, Radiobiology & Radiotherapy

dotlab logo

Dot Laboratories

Hugh Taylor, MD, Genomics, Genetics & Epigenetics

helix logo

Helix Therapeutics 

Peter Glazer, MD, PhD, Radiobiology & Radiotherapy

historx logo

HistoRx

David Rimm, MD, PhD, Signal Transduction 

IGIA Pharmaceuticals

Anton Bennett, PhD, Signal Transduction 

Immunova logo

Immunova

Tarek Fahmy, PhD, Developmental Therapeutics

inozyme logo

Inozyme

Demetrios Braddock, MD, PhD, Genomics, Genetics & Epigenetics

isoplexis logo

IsoPlexis

Rong Fan, PhD, Signal Transduction

jsgenetics

JS Genetics 

Allen Bale, MD, Genomics, Genetics & Epigenetics

kleo logo

Kleo Pharmaceuticals

David Spiegel, MD/PhD, Developmental Therapeutics 

kolltan

Kolltan Pharmaceuticals

Joseph Schlessinger, PhD, Signal Transduction

l 2 logo

L2 Diagnostics

Richard Flavell, PhD, FRS, Cancer Immunology and Joseph Craft, MD, Cancer Immunology

lifano

LIFNano Therapeutics

Tarek Fahmy, PhD, Developmental Therapeutics

mifcor logo

MIFCOR

Richard Bucala, MD, PhD, Cancer Immunology

MT logo

Modulate Therapeutics

Tarek Fahmy, PhD, Developmental Therapeutics

NextCure logo

NextCure 

Lieping Chen, MD, PhD, Cancer Immunology

patrys logo

Nucleus Therapeutics/Acquired by Patrys

James Hansen,  MD, MS, Radiobiology & Radiotherapy and Peter Glazer, MD, PhD, Radiobiology & Radiotherapy

Vyriad logo

Omnis Pharmaceuticals- merged to form Vyriad

John Rose, PhD, VOIC

osmol logo

Osmol Therapeutics

Barbara Ehrlich, PhD, Developmental Therapeutics

phlipinc logo

pHLIP Inc.

Donald Engelman, PhD, Developmental Therapeutics

phytoceutica logo

PhytoCeutica

Yung-Chi Cheng, PhD, Developmental Therapeutics 

Onyx logo

Proteolix/Acquired by Onyx Pharma

Craig Crews, PhD, Developmental Therapeutics

SurExam

Gil Mor, MD, PhD, MSc, Developmental Therapeutics 

Tummyzen logo

Tummyzen

John Geibel, DSc, MD, AGAF, MS, FRS, Signal Transduction

vedanta logo

Vedanta Biosciences 

Ruslan Medzhitov, PhD, Cancer Immunology

Yiviva logo

Yiviva

Yung-Chi Cheng, PhD, Developmental Therapeutics